Oct
2026
Fiera Milano, Italy
Visit us
stand 2H50, API
SynZeal Research Pvt Ltd.
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:India
-
On CPHI since:2017
-
Certificates:1
-
Employees:250 - 499
Company types
Primary activities
Contact info
-
-
-
Plot No. F, Shree Ganesh Industrial Estate, 382213, Gujarat,, India
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 2H50, API
Products Featured at CPHI Milan 2026
-
Product Apixaban
Apixaban is an oral anticoagulant belonging to the class of direct Factor Xa inhibitors. It works by blocking Factor Xa, an essential enzyme in the coagulation cascade, thereby reducing the formation of blood clots. Apixaban offers advantages over traditional anticoagulants like warfarin, including fewer f... -
Product Rivaroxaban
Rivaroxaban is an oral anticoagulant that belongs to the class of direct Factor Xa inhibitors. By selectively blocking Factor Xa, it interrupts the blood coagulation cascade, thereby preventing the formation of fibrin clots.. Rivaroxaban offers the advantage with predictable anticoagulant effects that elim... -
Product Linezolid (Form 2 & 3)
Linezolid is an oxazolidinone antibiotic used to treat serious infections caused by resistant Gram-positive bacteria, including MRSA and VRE. Form-3 offers advantages over Form-2 such as better patient compliance, easier dosing accuracy, and improved stability during storage and handling. ApiSyn offers hi... -
Product Semaglutide
Alogliptin Benzoate is an oral antidiabetic medication belonging to the DPP-4 (dipeptidyl peptidase-4) inhibitor class. It is used to improve glycemic control in adults with type 2 diabetes mellitus. It helps lower blood glucose by increasing incretin levels, which enhances insulin secretion and suppresses... -
Product Pharmaceutical Reference Standards
All Pharmaceutical Reference Standards are supplied with Certified COA along with supporting analytical data like HPLC, Mass, NMR, CMR, UV, IR, TGA, ROI, CHNS.
